NCT04539782

Brief Summary

The main objective is to assess the feasibility of a randomized controlled trial that investigates the effects of pelvic floor training on recurrence in pelvic organ prolapse surgeries. This will be achieved by measuring POP-Q stage and by a validated questionnaire before surgery and one year after. Women having POP surgery at Landspitali will be offered to participate if they meet the criteria of the research. Participants will be randomized into two groups, interventions and control group that gets standard care at the hospital. The intervention group will meet a physiotherapist 6 weeks post-op for targeted physiotherapy with pelvic floor training, conventional advice and support. Over 16 weeks period participants in intervention group will get physiotherapy four times and get two follow up phone calls. Pelvic floor activity will be measured with EMG and symptoms collected with questionnaire before surgery and year post-op. Recurrent surgeries are common problem shortly after the first one. POP symtoms can be bothersome for women and reduce their quality of life. More knowledge is needed to figure out if targeted physiotherapy with pelvic floor training can help reduce recurrency and bothersome symptoms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 7, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
Last Updated

September 7, 2020

Status Verified

August 1, 2020

Enrollment Period

1 year

First QC Date

August 31, 2020

Last Update Submit

August 31, 2020

Conditions

Keywords

pelvic floorphysiotherapypelvic organ prolapsepost oprecurrence

Outcome Measures

Primary Outcomes (1)

  • POP-Q

    POP-Q stages are measured by urogynocologists who are blinded outcome assessors.

    One year

Secondary Outcomes (1)

  • The Australian Female Pelvic Floor Questionnaire

    One year

Study Arms (2)

Physiotherapy intervention

EXPERIMENTAL

Pelvic floor muscle training given by a physiotherapist in four sessions and follow up phone calls twice in 14 weeks

Other: Physiotherapy intervention

No intervention

NO INTERVENTION

Standard care

Interventions

Compare the effect of structured pelvic floor muscle training supported by physiotherapist post operation on POP on recurrence of symptoms or symptoms in a new compartment, quality of life and pelvic floor muscle function.

Physiotherapy intervention

Eligibility Criteria

AgeUp to 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women having their first POP surgery at LSH
  • \<80 years old
  • Icelandic speaking

You may not qualify if:

  • Women that previously have had incontinence surgery, hysterectomy or previous POP surgery.
  • Dementia, physical disabilities that could affect the research, previous radiotherapy and neurological diseases.
  • Women participating in the research that need to have recurrent POP surgery or incontinence surgery within the year of the surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Landspitali University Hospital

Reykjavik, 101, Iceland

Location

MeSH Terms

Conditions

Pelvic Organ ProlapseRecurrence

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Officials

  • Þorgerður Sigurðardóttir, MSc

    Landspítali University Hospital/University of Iceland, Reykjavík, Iceland.

    PRINCIPAL INVESTIGATOR
  • Helga Medek, MD, MSc

    Landspítali University Hospital/University of Iceland, Reykjavík, Iceland.

    STUDY CHAIR
  • Þórarinn Sveinsson, PhD

    University of Iceland

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2020

First Posted

September 7, 2020

Study Start

June 10, 2020

Primary Completion

June 15, 2021

Study Completion

June 15, 2021

Last Updated

September 7, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations